N. B. Simpson

1.5k total citations
21 papers, 643 citations indexed

About

N. B. Simpson is a scholar working on Dermatology, Epidemiology and Molecular Biology. According to data from OpenAlex, N. B. Simpson has authored 21 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Dermatology, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in N. B. Simpson's work include Acne and Rosacea Treatments and Effects (6 papers), Dermatology and Skin Diseases (4 papers) and Hair Growth and Disorders (3 papers). N. B. Simpson is often cited by papers focused on Acne and Rosacea Treatments and Effects (6 papers), Dermatology and Skin Diseases (4 papers) and Hair Growth and Disorders (3 papers). N. B. Simpson collaborates with scholars based in United Kingdom, Australia and Germany. N. B. Simpson's co-authors include Marius Rademaker, J. Garioch, W.S. Douglas, Eugene Healy, W.J. Cunliffe, J. B. Neilly, Adam Martin, A C MacCuish, David Gould and Kathleen Rankin and has published in prestigious journals such as The Lancet, Diabetes Care and British Journal of Dermatology.

In The Last Decade

N. B. Simpson

21 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. B. Simpson United Kingdom 14 431 82 80 68 67 21 643
Ibrahim Galadari United Arab Emirates 15 312 0.7× 97 1.2× 52 0.7× 71 1.0× 59 0.9× 32 529
Ayten Ferahbaş Türkiye 14 285 0.7× 99 1.2× 54 0.7× 68 1.0× 86 1.3× 38 608
J.A. Cotterill United Kingdom 15 287 0.7× 59 0.7× 146 1.8× 124 1.8× 37 0.6× 45 634
Zeynep Demirçay Türkiye 15 419 1.0× 134 1.6× 53 0.7× 124 1.8× 60 0.9× 27 660
Paul Devakar Yesudian United Kingdom 13 252 0.6× 46 0.6× 90 1.1× 144 2.1× 33 0.5× 74 538
Rocío Orozco‐Topete Mexico 13 206 0.5× 58 0.7× 116 1.4× 154 2.3× 47 0.7× 32 504
Carol E. Cheng United States 12 369 0.9× 81 1.0× 43 0.5× 67 1.0× 35 0.5× 30 635
Behrooz Barikbin Iran 16 251 0.6× 49 0.6× 44 0.6× 61 0.9× 32 0.5× 42 547
Arzu Ataseven Türkiye 13 252 0.6× 77 0.9× 61 0.8× 113 1.7× 75 1.1× 81 607
Margaret Song South Korea 15 336 0.8× 59 0.7× 90 1.1× 119 1.8× 34 0.5× 46 574

Countries citing papers authored by N. B. Simpson

Since Specialization
Citations

This map shows the geographic impact of N. B. Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. B. Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. B. Simpson more than expected).

Fields of papers citing papers by N. B. Simpson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. B. Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. B. Simpson. The network helps show where N. B. Simpson may publish in the future.

Co-authorship network of co-authors of N. B. Simpson

This figure shows the co-authorship network connecting the top 25 collaborators of N. B. Simpson. A scholar is included among the top collaborators of N. B. Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. B. Simpson. N. B. Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dunning, Trisha, et al.. (2021). Discussing diabetes, palliative and end of life care: choosing the ‘right’ language. Annals of Palliative Medicine. 10(4). 3739–3749. 3 indexed citations
2.
Haniffa, Muzlifah, S. Leech, Sally Ann Lynch, & N. B. Simpson. (2004). NBCCS secondary to an interstitial chromosome 9q deletion. Clinical and Experimental Dermatology. 29(5). 542–544. 15 indexed citations
3.
Ozolins, Mara, E. Anne Eady, Anthony Avery, et al.. (2004). Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. The Lancet. 364(9452). 2188–2195. 114 indexed citations
4.
Gompels, Mark, et al.. (1999). Desensitization to co-trimoxazole (trimethoprimsulphamethoxazole) in HIV-infected patients: Is patch testing a useful predictor of reaction?. Journal of Infection. 38(2). 111–115. 21 indexed citations
6.
Berker, D. de, et al.. (1995). Reduced experimental contact sensitivity in squamous cell but not basal cell carcinomas of skin. The Lancet. 345(8947). 425–426. 13 indexed citations
7.
Douglas, W.S. & N. B. Simpson. (1995). Guidelines for the management of chronic venous leg ulceration. Report of a multidisciplinary workshop. British Journal of Dermatology. 132(3). 446–452. 68 indexed citations
8.
Healy, Eugene & N. B. Simpson. (1994). Fortnightly Review Acne vulgaris. BMJ. 308(6932). 831–833. 37 indexed citations
9.
Simpson, N. B.. (1994). Effect of Isotretinoin on the Quality of Life of Patients with Acne. PharmacoEconomics. 6(2). 108–113. 32 indexed citations
10.
Rademaker, Marius, et al.. (1993). Medical audit-need for a positive commitment. Clinical and Experimental Dermatology. 18(1). 17–20. 1 indexed citations
11.
Lamey, P.‐J., Terry D. Rees, William H. Binnie, et al.. (1992). Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy. Oral Surgery Oral Medicine Oral Pathology. 74(1). 54–57. 51 indexed citations
12.
Cunliffe, W.J., et al.. (1991). Cost effectiveness of isotretinoin. Journal of Dermatological Treatment. 1(6). 285–288. 24 indexed citations
13.
Rademaker, Marius, N. B. Simpson, Johannes Gudmundsson, et al.. (1991). Effect of the gonadotrophin releasing hormone analogue, goserelin, and oestradiol replacement on sebum excretion rates and hair size in mildly hirsute women. Journal of Dermatological Treatment. 1(6). 289–292. 3 indexed citations
14.
Shuttleworth, D., A.Y. Finlay, Marius Rademaker, C. Shaw, & N. B. Simpson. (1990). Psoriasis consultation audit: a two-centre study. British Journal of Dermatology. 123(1). 99–105. 2 indexed citations
15.
Rademaker, Marius, J. Garioch, & N. B. Simpson. (1989). Acne in schoolchildren: no longer a concern for dermatologists.. BMJ. 298(6682). 1217–1219. 110 indexed citations
16.
Civatte, J, et al.. (1987). 2% Topical Minoxidil Solution in Male-Pattern Baldness: Preliminary European Results. Dermatology. 175(Suppl. 2). 42–49. 17 indexed citations
17.
Neilly, J. B., Adam Martin, N. B. Simpson, & A C MacCuish. (1986). Pruritus in Diabetes Mellitus: Investigation of Prevalence and Correlation With Diabetes Control. Diabetes Care. 9(3). 273–275. 58 indexed citations
18.
Simpson, N. B.. (1984). The association between lichen sclerosus et atrophicus and auto-immune diseases in males is not proven. British Journal of Dermatology. 111(1). 121–122. 1 indexed citations
19.
Cunliffe, W.J., et al.. (1981). Acne vulgaris-its aetiology and treatment. A review*. Clinical and Experimental Dermatology. 6(5). 461–469. 40 indexed citations
20.
Simpson, N. B., Paul E. Bowden, W.J. Cunliffe, & R. A. FORSTER. (1978). Tolerance to the anti-seborrhoeic effect of topically applied progesterone. British Journal of Dermatology. 99(s16). 9–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026